Advanced glycation end-products: pathway of potentially significant pathophysiological and therapeutic relevance for metabolic syndrome in menopausal women

J Clin Endocrinol Metab. 2014 Apr;99(4):1146-8. doi: 10.1210/jc.2013-4465. Epub 2014 Feb 3.

Author

Affiliation

¹ Department of Obstetrics, Gynecology, and Reproductive Sciences, Division of Reproductive Endocrinology and Infertility, University of Vermont College of Medicine, Burlington, Vermont 05401.

PMID: 24491162
DOI: 10.1210/jc.2013-4465

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Animals
Cholesterol / blood
Estrogen Replacement Therapy / adverse effects
Female
Glycation End Products, Advanced / metabolism*
Humans
Hypolipidemic Agents / therapeutic use
Lipoproteins / blood
Menopause / metabolism*
Metabolic Syndrome / etiology
Metabolic Syndrome / metabolism*
Metabolic Syndrome / therapy*
Mice
Risk Factors
Signal Transduction / physiology
Triglycerides / blood
Waist Circumference / physiology

Substances

Glycation End Products, Advanced
Hypolipidemic Agents
Lipoproteins
Triglycerides
lipoprotein cholesterol
Cholesterol